BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30842805)

  • 1. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells in treating autism: Novel insights.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    World J Stem Cells; 2014 Apr; 6(2):173-8. PubMed ID: 24772244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.
    Gesundheit B; Ashwood P; Keating A; Naor D; Melamed M; Rosenzweig JP
    Med Hypotheses; 2015 Mar; 84(3):169-77. PubMed ID: 25592283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review.
    Tamouza R; Volt F; Richard JR; Wu CL; Bouassida J; Boukouaci W; Lansiaux P; Cappelli B; Scigliuolo GM; Rafii H; Kenzey C; Mezouad E; Naamoune S; Chami L; Lejuste F; Farge D; Gluckman E
    Front Cell Dev Biol; 2022; 10():809686. PubMed ID: 35865626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review.
    Nabetani M; Mukai T; Taguchi A
    Cell Transplant; 2023; 32():9636897231163217. PubMed ID: 36999673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model.
    Ha S; Park H; Mahmood U; Ra JC; Suh YH; Chang KA
    Behav Brain Res; 2017 Jan; 317():479-484. PubMed ID: 27717813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.
    Pistollato F; Forbes-Hernández TY; Calderón Iglesias R; Ruiz R; Elexpuru Zabaleta M; Cianciosi D; Giampieri F; Battino M
    Pharmacol Res; 2020 Feb; 152():104579. PubMed ID: 31790820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Atypicalities of Central Nervous System in Autism Spectrum Disorder.
    Shuid AN; Jayusman PA; Shuid N; Ismail J; Kamal Nor N; Naina Mohamed I
    Brain Sci; 2020 May; 10(5):. PubMed ID: 32443912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD).
    Hughes HK; Moreno RJ; Ashwood P
    Focus (Am Psychiatr Publ); 2024 Apr; 22(2):229-241. PubMed ID: 38680981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cell Secretions as a Potential Therapeutic Agent for Autism Spectrum Disorder: A Narrative Review.
    Darwish M; El Hajj R; Khayat L; Alaaeddine N
    Stem Cell Rev Rep; 2024 Jul; 20(5):1252-1272. PubMed ID: 38630359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation.
    Wikarska A; Roszak K; Roszek K
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Role of the Maternal Immune System in the Pathogenesis of Autism Spectrum Disorder.
    Ravaccia D; Ghafourian T
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33271759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder.
    Eve M; Gandawijaya J; Yang L; Oguro-Ando A
    Front Psychiatry; 2022; 13():842755. PubMed ID: 35492721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in autism spectrum disorders: Exercise as a "pharmacological" tool.
    Toscano CVA; Barros L; Lima AB; Nunes T; Carvalho HM; Gaspar JM
    Neurosci Biobehav Rev; 2021 Oct; 129():63-74. PubMed ID: 34310976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-emerging concepts of immune dysregulation in autism spectrum disorders.
    Erbescu A; Papuc SM; Budisteanu M; Arghir A; Neagu M
    Front Psychiatry; 2022; 13():1006612. PubMed ID: 36339838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies.
    Ansel A; Rosenzweig JP; Zisman PD; Melamed M; Gesundheit B
    Front Neurosci; 2016; 10():601. PubMed ID: 28105001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell-Derived Exosomes in Autism Spectrum Disorder.
    Alessio N; Brigida AL; Peluso G; Antonucci N; Galderisi U; Siniscalco D
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the use of stem cells for autism treatment.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    Stem Cells Int; 2013; 2013():262438. PubMed ID: 24222772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.